Page last updated: 2024-11-03

probucol and Capillary Leak Syndrome

probucol has been researched along with Capillary Leak Syndrome in 1 studies

Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.

Capillary Leak Syndrome: A condition characterized by recurring episodes of fluid leaking from capillaries into extra-vascular compartments causing hematocrit to rise precipitously. If not treated, generalized vascular leak can lead to generalized EDEMA; SHOCK; cardiovascular collapse; and MULTIPLE ORGAN FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonnardel-Phu, E1
Wautier, JL1
Schmidt, AM1
Avila, C1
Vicaut, E1

Other Studies

1 other study available for probucol and Capillary Leak Syndrome

ArticleYear
Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo.
    Diabetes, 1999, Volume: 48, Issue:10

    Topics: Albumins; Animals; Anticholesteremic Agents; Blood Glucose; Capillary Leak Syndrome; Diabetes Mellit

1999
chemdatabank.com